Searchable abstracts of presentations at key conferences in endocrinology
ea0070aep404 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020
Effects of azilsartan vs telmisartan on insulin resistance and metabolic biomarkers in patients of essential hypertension associated with type 2 diabetes mellitus: An open-label, randomized clinical trial
Background: Based on various preclinical studies, it is anticipated that azilsartan, an angiotensin II receptor blocker, will increase insulin sensitivity in addition to its antihypertensive effect. The present study was undertaken to evaluate the effect of azilsartan compared to telmisartan on insulin sensitivity in patients of hypertension coexisted with type 2 diabetes mellitus.Methods: This study was a prospective, randomized, active controlled, open...
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more